Germany’s Clinomic secures €23M to help doctors make faster ICU decisions: Know more
Aachen-based Clinomic, a German company providing acute and intensive care medicine, has closed a €23M Series B funding round.
Popular topics
Breaking news and analysis from technology, capital, and policy — the moves that matter for the people building, funding, and regulating the technology economy.
13,386 articles · News
Aachen-based Clinomic, a German company providing acute and intensive care medicine, has closed a €23M Series B funding round.
Netherlands-based BlueHeart Energy, a company developing Thermo Acoustic heat pump for the residential market, has received a strategic investment from Copeland, a US-based climate solutions provider.
Amsterdam-based Skytree, a climate tech company specialising in carbon utilisation and removal solutions, has secured investment from Division Q, Koppert Cress' innovation arm.
In the rapidly evolving landscape of biotechnology and cancer research, a growing number of companies are pushing the boundaries of what is possible in oncology.
Nine scale-ups have joined the latest Rise cohort by Techleap.nl!
Paris-based Klara, a provider of frontline employee skills management and workplace-based training solutions, has secured £8.5M (approximately €10M) in a funding round led by Endeit Capital.
Berlin-based Revent, a specialist early-stage venture capital firm investing across Europe, announced the launch of Fund II at €100M.
NCC Group, the global cybersecurity specialist and parent company of Fox-IT, has officially completed the sale of Fox Crypto to CR Group…
Copenhagen-based Sparrow Quantum, a supplier of photonic quantum chips, has raised €21.5M in a Series A funding round.
London-based DIG Ventures, an early-stage venture capital firm focused on B2B SaaS, AI, and cloud infrastructure startups in Europe, has closed a $100M (nearly €91M) fund.
London-based TransFICC, an e-trading technology company, announced a $25M (nearly €22.55M) Series B investment.
Delft-based Bi/ond, a biotechnology company specialised in drug discovery, is set to cease its operations.